1.08 USD
▲-0.03+1.89%
2026-08-03
市值
$8.25M
市盈率
—
EPS
-0.01
股息率
—
52 周区间
0.68 – 2.39
成交量
11.11K
Beta
0.50
目标价
—
52W 低 0.6852W 高 2.39
价格走势
公司简介
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive func...